Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study.
about
Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacologySerum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study.Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis
P2860
Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Adjunctive treatment for cogni ...... ind, placebo-controlled study.
@ast
Adjunctive treatment for cogni ...... ind, placebo-controlled study.
@en
type
label
Adjunctive treatment for cogni ...... ind, placebo-controlled study.
@ast
Adjunctive treatment for cogni ...... ind, placebo-controlled study.
@en
prefLabel
Adjunctive treatment for cogni ...... ind, placebo-controlled study.
@ast
Adjunctive treatment for cogni ...... ind, placebo-controlled study.
@en
P2093
P2860
P356
P1476
Adjunctive treatment for cogni ...... ind, placebo-controlled study.
@en
P2093
Jindong Chen
Jingfeng Qi
Jingping Zhao
Weiwei Zhu
Xiaofeng Guo
Zhanchou Zhang
P2860
P304
P356
10.2147/NDT.S64189
P407
P577
2014-07-14T00:00:00Z